This brand name is authorized in Poland
The drug RIVEL contains one active pharmaceutical ingredient (API):
1
Ethacridine lactate
UNII V5IL571C1T - ETHACRIDINE LACTATE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
D08AA01 | Ethacridine lactate | D Dermatologicals → D08 Antiseptics and disinfectants → D08A Antiseptics and disinfectants → D08AA Acridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: PL | Rejestru Produktรณw Leczniczych | Identifier(s): 100114249, 100314528 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.